BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28099917)

  • 1. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.
    Fontanil T; Álvarez-Teijeiro S; Villaronga MÁ; Mohamedi Y; Solares L; Moncada-Pazos A; Vega JA; García-Suárez O; Pérez-Basterrechea M; García-Pedrero JM; Obaya AJ; Cal S
    Oncotarget; 2017 Feb; 8(8):13716-13729. PubMed ID: 28099917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells.
    Fontanil T; Rúa S; Llamazares M; Moncada-Pazos A; Quirós PM; García-Suárez O; Vega JA; Sasaki T; Mohamedi Y; Esteban MM; Obaya AJ; Cal S
    Oncotarget; 2014 Mar; 5(5):1253-64. PubMed ID: 24457941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
    Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
    Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and Activity Determination of ADAMTS-4 and ADAMTS-5 and Their Domain Deleted Mutants.
    Fowkes MM; Lim NH
    Methods Mol Biol; 2020; 2043():75-91. PubMed ID: 31463904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.
    Ducros E; Berthaut A; Mirshahi P; Lemarchand S; Soria J; Legeais JM; Mirshahi M
    Curr Eye Res; 2007 Jun; 32(6):481-90. PubMed ID: 17612964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1.
    Lee NV; Rodriguez-Manzaneque JC; Thai SN; Twal WO; Luque A; Lyons KM; Argraves WS; Iruela-Arispe ML
    J Biol Chem; 2005 Oct; 280(41):34796-804. PubMed ID: 16061471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells.
    Mohamedi Y; Fontanil T; Solares L; Garcia-Suárez O; García-Piqueras J; Vega JA; Cal S; Obaya AJ
    Int J Oncol; 2016 Apr; 48(4):1447-56. PubMed ID: 26891749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of metalloprotease cleavage products of human articular cartilage.
    Zhen EY; Brittain IJ; Laska DA; Mitchell PG; Sumer EU; Karsdal MA; Duffin KL
    Arthritis Rheum; 2008 Aug; 58(8):2420-31. PubMed ID: 18668564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor Potential of Fibulin-5 in Breast Cancer Cells Depends on Its RGD Cell Adhesion Motif.
    Mohamedi Y; Fontanil T; Cobo T; Vega JA; Cobo JL; Pérez-Basterrechea M; Cobo J; Obaya ÁJ; Cal S
    Cell Physiol Biochem; 2019; 53(1):87-100. PubMed ID: 31204440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS-1 Is Found in the Nuclei of Normal and Tumoral Breast Cells.
    Silva SV; Lima MA; Cella N; Jaeger RG; Freitas VM
    PLoS One; 2016; 11(10):e0165061. PubMed ID: 27764205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of ADAMTS Proteases and Their Substrates in Epithelial Ovarian Cancer.
    Lima MA; Dos Santos L; Turri JA; Nonogaki S; Buim M; Lima JF; de Jesus Viana Pinheiro J; Bueno de Toledo Osório CA; Soares FA; Freitas VM
    Pathobiology; 2016; 83(6):316-26. PubMed ID: 27359117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GON-1 and fibulin have antagonistic roles in control of organ shape.
    Hesselson D; Newman C; Kim KW; Kimble J
    Curr Biol; 2004 Nov; 14(22):2005-10. PubMed ID: 15556862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrilin-4 is processed by ADAMTS-5 in late Golgi vesicles present in growth plate chondrocytes of defined differentiation state.
    Groma G; Grskovic I; Schael S; Ehlen HW; Wagener R; Fosang A; Aszodi A; Paulsson M; Brachvogel B; Zaucke F
    Matrix Biol; 2011 May; 30(4):275-80. PubMed ID: 21539915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma.
    Filou S; Stylianou M; Triantaphyllidou IE; Papadas T; Mastronikolis NS; Goumas PD; Papachristou DJ; Ravazoula P; Skandalis SS; Vynios DH
    Biochimie; 2013 Apr; 95(4):725-34. PubMed ID: 23131589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS proteases and cancer.
    Cal S; López-Otín C
    Matrix Biol; 2015; 44-46():77-85. PubMed ID: 25636539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Levels of A Disintegrin-like Metalloproteinase with Thrombospondin Motifs-4 and -5 (ADAMTS-4 and ADAMTS-5) in Inflamed and Healthy Gingival Tissues.
    Tayman MA; Koyuncu İ; Köklü NÖ
    Comb Chem High Throughput Screen; 2020; 23(2):168-176. PubMed ID: 32067610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
    Powell AJ; Little CB; Hughes CE
    Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of breast cancer response to chemotherapy by fibulin-1.
    Pupa SM; Giuffré S; Castiglioni F; Bertola L; Cantú M; Bongarzone I; Baldassari P; Mortarini R; Argraves WS; Anichini A; Menard S; Tagliabue E
    Cancer Res; 2007 May; 67(9):4271-7. PubMed ID: 17483339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
    Pattoli MA; MacMaster JF; Gregor KR; Burke JR
    J Pharmacol Exp Ther; 2005 Oct; 315(1):382-8. PubMed ID: 16009742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.